Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

X4 Pharmaceuticals, Inc (XFOR) Institutional Ownership & Insider Trading

89 institutions reported holding X4 Pharmaceuticals, Inc shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 7 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

XFORX4 Pharmaceuticals, IncFollow XFOR — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
321.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
3 Nov, in 10 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

89 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +7.0%.

Increased+24New+32Decreased-12Closed-25

Largest moves, shares (millions)

BlackRock+4.3MNantahala Capital Management+2.4MVenrock Adviser+1.6MEmpery Asset Management-2.0MStempoint Capital-1.7MMillennium Management-1.2M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-1.7Sep 24-7.9Dec 24+0.0Mar 25+0.0Jun 25+13.4Sep 25+58.0Dec 25+8.4Mar 26+6.9Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2689105+7.0%24321225
Mar 268398+10.1%23141910
Dec 257989+359.1%173884
Sep 254216+475.6%1210920
Jun 25513—————
Mar 2520—————
Dec 2489100-7.9%22112020
Sep 2498101-1.9%3291710

X4 Pharmaceuticals, Inc — questions

Who owns X4 Pharmaceuticals, Inc stock?
89 institutions reported X4 Pharmaceuticals, Inc shares in 13F filings for the quarter ended 2026-06-30. The largest: MORGAN STANLEY (9.5%), FMR LLC (8.4%), Bain Capital Life Sciences Investors, LLC (8.0%).
Are X4 Pharmaceuticals, Inc insiders buying or selling?
7 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from X4 Pharmaceuticals, Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.